McKesson : OJEMDA FDA Approved for Pediatric Low Grade Glioma
CARY, N.C., April 26, 2024 -Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare disease, was selected by Day One Biopharmaceuticals, as a limited...
George Paschal Specialty Solutions Drug Administration Sarah Cannon Research Institute Us Oncology Network Business Development For Biologics
Source: marketscreener.com